Have a personal or library account? Click to login
Evaluation of Clinical, Laboratory and Treatment Modalities in C3 Glomerulopathy: Single Center Experience Cover

Evaluation of Clinical, Laboratory and Treatment Modalities in C3 Glomerulopathy: Single Center Experience

PRILOZI
Volume 40 (2019): Issue 2 (October 2019)
By: H. Hasan Yeter,  Erdem Sütiçen,  Berfu Korucu,  Özant Helvaci,  Burak Özbaş,  İpek Gönül,  Ülver Derici,  Turgay Arinsoy and  Galip Güz  
Open Access
|Oct 2019
DOI: https://doi.org/10.2478/prilozi-2019-0010 | Journal eISSN: 1857-8985 | Journal ISSN: 1857-9345
Journal RSS Feed
Language: English
Page range: 15 - 23
Published on: Oct 11, 2019
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
C3 glomerulopathy,
eculizumab,
end stage renal disease,
mycophenolate mofetil
Related subjects:
Medicine,
Basic medical science,
History and ethics of medicine,
Clinical medicine,
Clinical medicine, other,
Social sciences,
Education,
Education, other

© 2019 H. Hasan Yeter, Erdem Sütiçen, Berfu Korucu, Özant Helvaci, Burak Özbaş, İpek Gönül, Ülver Derici, Turgay Arinsoy, Galip Güz, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 40 (2019): Issue 2 (October 2019)Next article